Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2583]

ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma

ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma

Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers

Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers

Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies

Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Common prostate cancer medications may be less safe than previously thought

Common prostate cancer medications may be less safe than previously thought

DWI for detection of locally recurrent pancreatic cancer

DWI for detection of locally recurrent pancreatic cancer

Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein

Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional...

Solid tumours use a type of T cell as a shield against immune attack

Solid tumours use a type of T cell as a shield against immune attack

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment

Study modeling tumour evolution reveals a vulnerability for cancer prevention and therapy

Study modeling tumour evolution reveals a vulnerability for cancer prevention and therapy

More from ecancer